Javascript is disabled in your browser

Startbase requires Javascript in order to display content.
Please check your browser settings and enable Javascript-Support for this website.

Synbiotic

News Synbiotic SE takes over parts of several hemp companies The start-up paid 11.2 million euros for this, but was also able to raise its turnover forecast for 2021 to 15 million euros.

Felix Leitmeyer 01.12.2021

News Synbiotic raises seven million euros The cannabis company has been listed on the German stock exchange since 2019. It has now issued 334,000 new shares.

Sophie Deistler 28.10.2021

News Synbiotic launches CBD without hemp on the market The start-up extracts the cannabinoids from hops, among other things. This should allow the CBD products to be sold in countries that prohibit hemp.

Tom Schmidtgen 23.07.2021

News Synbiotic launches joint venture of beverage professionals Synbiotic enters new spheres and founds a joint venture under the name Princess Stardurst, whose products are primarily aimed at the lifestyle market. Business angels are the Thomas Henry Managing Director and the...

Lisa Marie Münster 29.06.2021

News Synbiotic takes over GECA Pharma The cannabinoid start-up is thus adding the next company to its group of companies. Synbiotic is now also entering the medical cannabis market.

Jan Schulte 20.05.2021

News Synbiotic invests in Canadian cannabinoid company The cannabinoid start-up has subscribed to a convertible bond in the amount of two million US dollars. There is also an option to acquire NeuroTheryX outright.

Jan Schulte 07.04.2021

News BGH ruling gives CBD start-ups a boost According to a ruling by the Federal Court of Justice, the sale of CBD flowers to customers may be legal. However, one decisive restriction remains.

Jan Schulte 29.03.2021

1